QQ客服 官方微博 反馈留言

浏览/检索结果: 共22条，第1-10条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Prognostic significance of ST6GalNAc-1 expression in patients with non-metastatic clear cell renal cell carcinoma 期刊论文 ONCOTARGET, 2018, 卷号: 9, 期号: 3 作者:  Bai, Qi;  Liu, Li;  Xi, Wei;  Wang, Jiajun;  Xia, Yu 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/05 clear cell renal cell carcinoma  a-GalNAc a-2,6-sialyltransferase 1  nomogram  overall survival  recurrence free survival   RECORD-4 multicenter phase 2 trial of second-line everolimus in patients with metastatic renal cell carcinoma: Asian versus non-Asian population subanalysis 期刊论文 BMC CANCER, 2018, 卷号: 18 作者:  Yang, Lin;  Alyasova, Anna;  Ye, Dingwei;  Ridolfi, Antonia;  Dezzani, Luca 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05 Asians  Everolimus  Ethnicity  Clear-cell metastatic renal cell carcinoma  Sequence   A Genetic Polymorphism in CTLA-4 Is Associated with Overall Survival in Sunitinib-Treated Patients with Clear Cell Metastatic Renal Cell Carcinoma 期刊论文 CLINICAL CANCER RESEARCH, 2018, 卷号: 24, 期号: 10, 页码: 2350-2356 作者:  Liu, Xiaoyan;  Swen, Jesse J.;  Diekstra, Meta H. M.;  Boven, Epie;  Castellano, Daniel 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/11 Reintroducing Pazopanib Reverses the Primary Resistance of Nivolumab in a Patient With Metastatic Clear-cell Renal Cell Carcinoma 期刊论文 CLINICAL GENITOURINARY CANCER CLINICAL GENITOURINARY CANCER, 2018, 卷号: Vol.16 No.2, 页码: 114-116 作者:   收藏  |  浏览/下载：2/0  |  提交时间：2019/12/26 Immune  checkpoint  inhibitor  Pazopanib  Renal  cell  carcinoma  Resistance  VEGF   RECORD-4 multicenter phase 2 trial of second-line everolimus in patients with metastatic renal cell carcinoma: Asian versus non-Asian population subanalysis 期刊论文 2018, 卷号: 18, 期号: 1, 页码: 195 作者:  Yang, Lin;  Alyasova, Anna;  Ye, Dingwei;  Ridolfi, Antonia;  Dezzani, Luca 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03 Asians  Everolimus  Ethnicity  Clear-cell metastatic renal cell carcinoma  Sequence   High CXC chemokine receptor 1 level represents an independent negative prognosticator in non-metastatic clear-cell renal cell carcinoma patients 期刊论文 ONCOIMMUNOLOGY, 2017, 卷号: 6, 期号: 11 作者:  Zhu, Yu;  Liu, Zheng;  Wang, Yiwei;  Fu, Hangcheng;  Wang, Zewei 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05 clear-cell renal cell carcinoma  CXC chemokine receptor 1  overall survival  prognostic biomarker  recurrence-free survival   IRF5 is associated with adverse postoperative prognosis of patients with non-metastatic clear cell renal cell carcinoma 期刊论文 ONCOTARGET, 2017, 卷号: 8, 期号: 27 作者:  Bai, Qi;  Liu, Li;  Xia, Yu;  Wang, Jiajun;  Xi, Wei 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05 clear cell renal cell carcinoma  IFN regulatory factor-5  nomogram  overall survival  recurrence free survival   High expression of Mucin13 associates with grimmer postoperative prognosis of patients with non-metastatic clear-cell renal cell carcinoma 期刊论文 ONCOTARGET, 2017, 卷号: 8, 期号: 5 作者:  Xu, Zhiying;  Liu, Yidong;  Yang, Yuanfeng;  Wang, Jieti;  Zhang, Guodong 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05 clear-cell renal cell carcinoma  MUC13  overall survival  recurrence-free survival  prognostic biomarker   Prognostic value of granulocyte colony-stimulating factor in patients with non-metastatic clear cell renal cell carcinoma 期刊论文 ONCOTARGET, 2017, 卷号: 8, 期号: 41 作者:  Li, Gaoxiang;  Liu, Zheng;  Zhu, Yu;  Wang, Yiwei;  Fu, Qiang 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05 carcinoma  renal cell  granulocyte colony-stimulating factor  prognosis  neoplasm recurrence   Beta-1,4-galactosyltransferase II predicts poor prognosis of patients with non-metastatic clear-cell renal cell carcinoma 期刊论文 TUMOR BIOLOGY, 2017, 卷号: 39, 期号: 2 作者:  Xu, Le;  Zhang, Haijian;  Liu, Yidong;  Xie, Huyang;  Fu, Qiang 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05 Beta-1,4-galactosyltransferase II  clear-cell renal cell carcinoma  prognostic biomarker  overall survival  recurrence-free survival